Nursing Care for Cancer Patients with Venous Thromboembolism Receiving Anticoagulant Drugs
Keywords:
venous thromboembolism, cancer patients, anticoagulant drugs, nursing careAbstract
Venous thromboembolism (VTE) is a common complication in cancer patients. It includes deep vein thrombosis and pulmonary embolism, which are major causes of mortality and disability in cancer patients. Anticoagulant drugs are commonly used to treat cancer patients with VTE; however, the main complications of anticoagulant drugs are major organ bleeding and thrombocytopenia. As such, nurses and other health personnel play a major role in caring for cancer patients with VTE in dispensing anticoagulant drugs correctly and safely to help patients avoid severe complications.
References
Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer 2013;119(3):648-55.
Streiff MB. Thrombosis in the setting of cancer. Hematology Am Soc Hematol Educ Program 2016;2016(1):196-205.
Mandala M, Falanga A, Roila F; ESMO Guidelines Working Group. Management of venous thromboembolism (VTE) in cancer patients: ESMO clinical practice guidelines. Ann Oncol 2011;22(Suppl. 6):vi85-92.
National Comprehensive Cancer Network. Cancer Associated Venous Thromboembolic Disease NCCN Guidelines Version 3.2021 [Internet]. 2021 [cited 2021 Nov 21]. Available from: https://www.nccn.org/professionals/ physician_gls/pdf/vte.pdf
Wells P, Anderson D. The diagnosis and treatment of venous thromboembolism. Hematology Am Soc Hematol Educ Program 2013;2013:457-63.
Park DY, Khorana AA. Risks and benefits of anticoagulation in cancer and noncancer patients. Semin Thromb Hemost 2019;45(6):629-37.
Hawbaker S. Venous thromboembolism in the cancer population: pathology, risk, and prevention. J Adv Pract Oncol 2012;3(1):23-33.
Gee E. Principles and nursing management of anticoagulation. Nurs Stand 2018;32(23):50-63.
Mahajan A, Brunson A, White R, Wun T. The epidemiology of cancer-associated venous thromboembolism: an update. Semin Thromb Hemost 2019;45(4):321-5.
Schmaier AA, Ambesh P, Campia U. Venous thromboembolism and cancer. Curr Cardiol Rep 2018;20(10):89. doi: 10.1007/s11886-018-1034-3
Donnellan E, Khorana AA. Cancer and venous thromboembolic disease: a review. Oncologist 2017;22(2):199-207.
Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111(10):4902-7.
Hiraide M, Shiga T, Minowa Y, Nakano Y, Yoshioka H, Suzuki K, et al. Identification of risk factors for venous thromboembolism and evaluation of Khorana venous thromboembolism risk assessment in Japanese lung cancer patients. J Cardiol 2020;75(1):110-4.
Tanapathomsinchai N, Dechaphunkul A, Sathitruangsak C. Cancer-associated Thromboembolism. Songkla Med J 2014;32(3):185-93. (in Thai)
Harter K, Levine M, Henderson SO. Anticoagulation drug therapy: a review. West J Emerg Med 2015;16(1):11-7.
Bellesoeur A, Thomas-Schoemann A, Allard M, Smadja D, Vidal M, Alexandre J, et al. Pharmacokinetic variability of anticoagulants in patients with cancer-associated thrombosis: clinical consequences. Crit Rev Oncol Hematol 2018;129(3):102-12.
Tsegaye D, Alem G, Tessema Z, Alebachew W. Medication administration errors and associated factors among nurses. Int J Gen Med 2020;13:1621-32.
Pharmaceutical and therapeutic Committee, Siriraj Hospital. High alert drug [Internet]. 2021 [cited 2021 Dec 1]. Available from: https://www2.si.mahidol.ac.th/km/cop/clinical/ medication safety/highalertdrug/7684/ (in Thai)
Office of the Permanent Secretary, Ministry of Public Health. Wafarin clinic management [Internet]. 2016 [cited 2021 Dec 1]. Available from: http://61.19.22.109/ ncd/htm/work/Warfarin Managenent.pdf (in Thai)
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Srisavarindhira Thai Red Cross Institute of Nursing
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
เนื้อหาบทความหรือข้อคิดเห็นต่างๆ ในวารสารพยาบาลสภากาชาดไทยนี้ เป็นความคิดเห็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการ หรือสถาบันการพยาบาลศรีสวรินทิรา สภากาชาดไทย
